We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
TriNet
TNET
$2.98B
| $213K | 0.12% |
+10,000
| New | +$206K |
2014 Q1
0 quarters
|
|
152
Curis
CRIS
$1.56M
| $212K | 0.11% |
38
| – | – |
2013 Q2
3 quarters
|
|
|
VMEM
153
DELISTED
VIOLIN MEMORY, INC.
VMEM
| $212K | 0.11% |
13,250
-7,339
| -36% | -$119K |
2013 Q3
2 quarters
|
|
|
MBII
154
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $210K | 0.11% |
15,000
-5,000
| -25% | -$78.5K |
2013 Q4
1 quarter
|
|
155
Zoetis
ZTS
$31.3B
| $203K | 0.11% |
7,000
| – | – |
2013 Q4
1 quarter
|
|
156
DELISTED
Jive Software, Inc.
JIVE
| $200K | 0.11% |
+25,000
| New | +$224K |
2014 Q1
0 quarters
|
|
|
ANAC
157
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $200K | 0.11% |
10,000
-10,000
| -50% | -$194K |
2013 Q4
1 quarter
|
|
158
OraSure Technologies
OSUR
$270M
| $199K | 0.11% |
25,000
| – | – |
2013 Q4
1 quarter
|
|
159
FuelCell Energy
FCEL
$1.31B
| $186K | 0.1% |
17
| – | – |
2013 Q3
2 quarters
|
|
160
DELISTED
Fortress Investment Group Llc
FIG
| $185K | 0.1% |
25,000
| – | – |
2013 Q2
3 quarters
|
|
161
Pure Cycle
PCYO
$271M
| $182K | 0.1% |
30,000
+5,000
| +20% | +$31.4K |
2013 Q2
3 quarters
|
|
162
Orion Energy Systems
OESX
$104M
| $181K | 0.1% |
+2,500
| New | +$157K |
2014 Q1
0 quarters
|
|
|
ROX
163
DELISTED
Castle Brands, Inc.
ROX
| $180K | 0.1% |
150,000
+75,000
| +100% | +$69.8K |
2013 Q2
3 quarters
|
|
164
Century Casinos
CNTY
$23.6M
| $179K | 0.1% |
25,000
| – | – |
2013 Q4
1 quarter
|
|
|
JCP
165
CALL
DELISTED
J.C. Penney Company, Inc.
JCP
| $172K | 0.09% |
+20,000
| New | +$144K |
2014 Q1
0 quarters
|
|
|
FMBI
166
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $171K | 0.09% |
+10,000
| New | +$168K |
2014 Q1
0 quarters
|
|
167
DELISTED
Primo Water Corporation
PRMW
| $169K | 0.09% |
20,000
-30,000
| -60% | -$242K |
2013 Q3
2 quarters
|
|
|
RSH
168
DELISTED
RADIOSHACK CORP
RSH
| $159K | 0.09% |
+75,000
| New | +$176K |
2014 Q1
0 quarters
|
|
169
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $158K | 0.09% |
175,000
| – | – |
2013 Q2
3 quarters
|
|
170
DELISTED
Xoma
XOMA
| $156K | 0.08% |
1,500
-1,100
| -42% | -$160K |
2013 Q4
1 quarter
|
|
|
ECTE
171
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $150K | 0.08% |
50,000
| – | – |
2013 Q2
3 quarters
|
|
172
DELISTED
Kinder Morgan Inc
KMI.WS
| $150K | 0.08% |
+85,000
| New | +$215K |
2014 Q1
0 quarters
|
|
173
Banco Santander
SAN
$195B
| $149K | 0.08% |
17,154
-10,370
| -38% | -$84.8K |
2013 Q4
1 quarter
|
|
|
HDNG
174
DELISTED
Hardinge Inc
HDNG
| $144K | 0.08% |
10,000
| – | – |
2013 Q2
3 quarters
|
|
175
DELISTED
GENERAL MTRS CO WTS EXP 12/31/15 (DE)
GM.WS.C
| $141K | 0.08% |
50,000
| – | – |
2013 Q3
2 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.